These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1569149

  • 1. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
    Reaven GM, Johnston P, Hollenbeck CB, Skowronski R, Zhang JC, Goldfine ID, Chen YD.
    J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM.
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [Abstract] [Full Text] [Related]

  • 5. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
    Jeppesen J, Zhou MY, Chen YD, Reaven GM.
    Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA, Barzilai N, Simonson DC.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
    Mughal MA, Jan M, Maheri WM, Memon MY, Ali M.
    J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
    [Abstract] [Full Text] [Related]

  • 9. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 10. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
    Wu MS, Johnston P, Sheu WH, Hollenbeck CB, Jeng CY, Goldfine ID, Chen YD, Reaven GM.
    Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
    [Abstract] [Full Text] [Related]

  • 11. Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.
    Hollenbeck CB, Chen YD, Greenfield MS, Lardinois CK, Reaven GM.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):605-8. PubMed ID: 3511084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JM, Fraser W, Anderson C, White A, Young RJ.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [Abstract] [Full Text] [Related]

  • 15. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL, Jacobson RK, Porte D, Kahn SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [Abstract] [Full Text] [Related]

  • 16. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA, Patti L, Romano G, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [Abstract] [Full Text] [Related]

  • 17. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Brignetti D, Luo J, Khandwala A, Reaven GM.
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.